Literature DB >> 11676986

The epidemiology of motor neuron diseases: a review of recent studies.

P M Worms1.   

Abstract

As the incidence and mortality rates of motor neuron diseases (MNDs) have been reported to increase steadily over the 1950s-1980s decades, we compared the results of the most recent studies (1990s decade) with the ones reported for those earlier periods. The relevant literature was retrieved on a keyword basis from online medical and official death statistics databases. Fifteen European and North American studies were analyzed, for comparison with the results reported in review papers. The 1990s incidence and mortality rates of MND average at 1.89 per 100,000/year and 1.91 per 100,000/year, respectively, thus yielding increases of 46% and 57% over the 1960s-1970s decades, respectively. This increase appears mainly due to Southern Europe countries, to female gender and to patients aged 75 years and over.Thus, the results of this analysis (i) confirm that the incidence of, and mortality from, MNDs continued to increase during the 1990s and, (ii) suggest that this increase could be partly due to increased life expectancy. Other factors might also contribute, such as better diagnosis since El Escorial criteria, and better accuracy of death certificate collection.However, a real increase in the incidence of MNDs, possibly related to environmental factors, cannot be excluded.

Entities:  

Mesh:

Year:  2001        PMID: 11676986     DOI: 10.1016/s0022-510x(01)00630-x

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  56 in total

1.  Discovery and verification of amyotrophic lateral sclerosis biomarkers by proteomics.

Authors:  Henrik Ryberg; Jiyan An; Samuel Darko; Jonathan Llyle Lustgarten; Matt Jaffa; Vanathi Gopalakrishnan; David Lacomis; Merit Cudkowicz; Robert Bowser
Journal:  Muscle Nerve       Date:  2010-07       Impact factor: 3.217

Review 2.  Diagnosis and management of motor neurone disease.

Authors:  Christopher J McDermott; Pamela J Shaw
Journal:  BMJ       Date:  2008-03-22

3.  The role of environmental mercury, lead and pesticide exposure in development of amyotrophic lateral sclerosis.

Authors:  Frank O Johnson; William D Atchison
Journal:  Neurotoxicology       Date:  2009-07-24       Impact factor: 4.294

4.  Earliest videofluoromanometric pharyngeal signs of dysphagia in ALS patients.

Authors:  Antonio Solazzo; Luigi Monaco; Lucia Del Vecchio; Alfonso Reginelli; Francesca Iacobellis; Raffaella Capasso; Stefania Tamburrini; Daniela Berritto; Maria Rosaria Barillari; Maria Rosaria Monsurrò; Natale Di Martino; Roberto Grassi
Journal:  Dysphagia       Date:  2014-08-21       Impact factor: 3.438

5.  Meditation training for people with amyotrophic lateral sclerosis and their caregivers.

Authors:  Francesco Pagnini; Chiara Di Credico; Ramona Gatto; Viviana Fabiani; Gabriella Rossi; Christian Lunetta; Anna Marconi; Federica Fossati; Gianluca Castelnuovo; Aurora Tagliaferri; Paolo Banfi; Massimo Corbo; Valeria Sansone; Enrico Molinari; Gherardo Amadei
Journal:  J Altern Complement Med       Date:  2013-12-11       Impact factor: 2.579

6.  DNA base-excision repair enzyme apurinic/apyrimidinic endonuclease/redox factor-1 is increased and competent in the brain and spinal cord of individuals with amyotrophic lateral sclerosis.

Authors:  Arif Y Shaikh; Lee J Martin
Journal:  Neuromolecular Med       Date:  2002       Impact factor: 3.843

7.  Comparison of the extraction and determination of serum exosome and miRNA in serum and the detection of miR-27a-3p in serum exosome of ALS patients.

Authors:  Qian Xu; Yuying Zhao; Xiaoyan Zhou; Jing Luan; Yazhou Cui; Jinxiang Han
Journal:  Intractable Rare Dis Res       Date:  2018-02

8.  Arylazanylpyrazolone derivatives as inhibitors of mutant superoxide dismutase 1 dependent protein aggregation for the treatment of amyotrophic lateral sclerosis.

Authors:  Yinan Zhang; Radhia Benmohamed; He Huang; Tian Chen; Cindy Voisine; Richard I Morimoto; Donald R Kirsch; Richard B Silverman
Journal:  J Med Chem       Date:  2013-03-15       Impact factor: 7.446

9.  Trends in death certification for multiple sclerosis, motor neuron disease, Parkinson's disease and epilepsy in English populations 1979-2006.

Authors:  Michael J Goldacre; Marie Duncan; Myfanwy Griffith; Martin R Turner
Journal:  J Neurol       Date:  2009-11-28       Impact factor: 4.849

Review 10.  Amyotrophic lateral sclerosis.

Authors:  Lokesh C Wijesekera; P Nigel Leigh
Journal:  Orphanet J Rare Dis       Date:  2009-02-03       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.